The Conversation (0)
Ayurcann Holdings Corp. (CSE: AYUR,OTC:AYURF, OTCQB: AYURF) (" Ayurcann " or the " Company ") is excited to announce its financial and operational results for the three months ended September 30, 2025, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of unaudited condensed interim consolidated financial statements for the three months ended September 30, 2025 and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.Ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca .
Q1 2026 Highlights: Consistent Execution
Revenue: Ayurcann generated $14,638,697 in gross revenue, with gross profit of $2,236,343 and a healthy gross margin of 26% in Q1 2026 (vs. $14,657,485 in gross revenue, with gross profit of $3,321,974 and a gross margin of 40% in Q1 2025), reflecting continued robust demand across our expanding product categories and successful national distribution efforts.
Market Share Leadership: Ayurcann is now recognized as a Top 3 vape producer in Ontario by volume , with a 5% share of the national vape market and 7% share in Ontario , underscoring our dominance in one of Canada's fastest-growing categories. 1
A High-Performance Operator
Operational Discipline: Ayurcann has emerged as one of Canada's most efficient and reliable cannabis manufacturers, consistently delivering strong output, quality, and on-time execution.
Accelerating Innovation: Over the past six months alone, the Company has rolled out 30 new stock keeping units across leading consumer categories – vapes, pre-rolls, and concentrates – driving expanded shelf presence and broader retail adoption.
Engines of Sustained Growth
Ayurcann's leadership in the vape segment creates a powerful foundation for growth as we scale aggressively into high-demand pre-rolls and concentrates, with distribution across many licensed stores in Canada, Ayurcann continues to strengthen its position as a trusted national supplier for retailers and consumers alike.
For further information, please contact:
Igal Sudman, Chief Executive Officer
Ayurcann Holdings Corp.
Tel: 905-492-3322
Email: info@Ayurcann.com
Investor Relations:
About Ayurcann:
Ayurcann is a leading cannabis licenced producer concentrating on the recreational market in Canada with proprietary products and formulations including Vape Carts, Pre-rolls, Concentrates and Extracts.
For more information about Ayurcann, please visit www.Ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca .
Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "strategy", "expects" or "does not expect", "intends", "continues", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "will be taken", "will launch" or "will be launching", "will include", "will allow", "will be made" "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the Company meeting its goals and strategic focuses as set out herein; the Company continuing to grow, expand and capitalize on its revenue, sales and growth trajectory; the future growth of the cannabis industry; the Company being well-positioned for long-term growth, profitability, success, performance, value creation and providing shareholder returns; the Company scaling into high-demand pre-rolls and concentrates; the Company entering new markets, strengthening retail partnerships, and increasing product listings nationwide; and the Company continuing to be a leading player in the cannabis industry.
Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company will focus on custom processes and pharma grade products for the adult use and medical cannabis industry in Canada; the Company will have the ability to meet its goals and strategic focuses as set out herein; the Company will have the ability to continue to grow, expand and capitalize on its revenue, sales and growth trajectory; cannabis industry will continue to grow; the Company will continue to have long-term growth, profitability, success, performance, value creation and provide shareholder returns; the Company will scale into high-demand pre-rolls and concentrates; the Company will enter new markets, strengthen retail partnerships, and increase product listings nationwide; and the Company will continue to be a leading player in the cannabis industry.
These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the Company's inability to meet its goals and strategic focuses as set out herein; the Company's inability to continue to grow, expand and/or capitalize on its revenue, sales and/or growth trajectory; growth of the cannabis industry declining and/or plateauing; Company growth, profitability, performance, value creation and/or shareholder returns declining and/or plateauing; the Company's inability to scale into high-demand pre-rolls and/or concentrates; the Company's inability to enter into new markets, strengthen retail partnerships, and/or increase product listings nationwide; and the Company not being a leading player in the cannabis industry.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions, or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Risk Factors" in the Company's public disclosure, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca , which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events, or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
1 Based on reporting by Hifyre IQTM, as of September 30, 2025.
